Prosecution Insights
Last updated: May 29, 2026

Sanford Burnham Prebys Medical Discovery Institute

12 pending office actions • 11 art units • 12 examiners • 0 of 12 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days

Portfolio Summary

12
Total Pending OAs
8
Non-Final OAs
2
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 12 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

10
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 12 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (10)Due ≤ 30 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
7
Medium (58%)
0
Easy (0%)
5
Unknown (42%)

Rejection Statute Mix

BucketCases
§103 only7 (58%)
No statute on record5 (42%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

12
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

120 h
Manual time on pending OAs
24 h
Time saved (low, 20%)
42 h
Time saved (mid, 35%)
1.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HA, JULIE 1 75.6% +44.4%
KIM, DANIELLE A 1 37.2% +58.0%
ULLMAN, AARON RAFANAN 1
XU, XIAOYUN 1 59.6% +32.3%
YOO, SUN JAE 1 71.0% +0.0%
MCKOY, QUINCY ANDRE 1 68.5% +41.7%
CLARKE, TRENT R 1 41.2% +26.0%
LEVIN, JOEL D 1 52.3% +58.4%
MELLER, MICHAEL V 1 46.1% +28.6%
BRADLEY, CHRISTINA 1 62.7% +33.2%

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17827584 COMPOSITIONS AND METHODS FOR TREATING NERVOUS SYSTEM INJURIES BRADLEY, CHRISTINA 103d overdue
17828627 METHOD FOR IMPROVING DIGESTIVE HEALTH MELLER, MICHAEL V 67d overdue
18056682 METHODS AND COMPOSITIONS FOR TREATING ATHEROSCLEROSIS MCKOY, QUINCY ANDRE 60d overdue
18419387 TYRAMINE CONTAINING HYDROXYCINNAMIC ACID AMIDE DERIVATIVES AND METHODS OF USE THEREOF KIM, DANIELLE A 50d overdue
17906818 COMPOSITIONS AND METHODS FOR TREATING SERRATED COLORECTAL CANCER CLARKE, TRENT R 42d overdue
17790052 METHODS AND COMPOSITIONS FOR BINDING IMMUNOGLOBULIN PROTEIN TARGETING LEVIN, JOEL D 42d overdue
18361439 METHODS AND COMPOSITIONS FOR DETECTING COGNITIVE DISORDER XU, XIAOYUN 35d overdue
18652429 TUMOR ASSOCIATED MONOCYTE/MACROPHAGE BINDING PEPTIDE AND METHODS OF USE THEREOF HA, JULIE 14d

Top Art Units

Art UnitApps
1654 2
1613 1
1628 1
1797 1
1621 1
1626 1
1651 1
1633 1
1655 1
1611 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18652429 TUMOR ASSOCIATED MONOCYTE/MACROPHAGE BINDING PEPTIDE AND METHODS OF USE THEREOF HA, JULIE 1654 §103 Non-Final OA 14d Pending May 01, 2024
18419387 TYRAMINE CONTAINING HYDROXYCINNAMIC ACID AMIDE DERIVATIVES AND METHODS OF USE THEREOF KIM, DANIELLE A 1613 Other Non-Final OA 50d overdue Pending Jan 22, 2024
18415255 USES OF HNF4 ALPHA AGONISTS ULLMAN, AARON RAFANAN 1628 §103 Non-Final OA 62d Pending Jan 17, 2024
18361439 METHODS AND COMPOSITIONS FOR DETECTING COGNITIVE DISORDER XU, XIAOYUN 1797 §103 Non-Final OA 35d overdue Pending Jul 28, 2023
17928468 ENHANCERS OF PARTICULATE GUANYLYL CYCLASE RECEPTOR A YOO, SUN JAE 1621 Other Non-Final OA 26d overdue Pending Nov 29, 2022
18056682 METHODS AND COMPOSITIONS FOR TREATING ATHEROSCLEROSIS MCKOY, QUINCY ANDRE 1626 §103 Non-Final OA 60d overdue Pending Nov 17, 2022
17906818 COMPOSITIONS AND METHODS FOR TREATING SERRATED COLORECTAL CANCER CLARKE, TRENT R 1651 Other Non-Final OA 42d overdue Pending Sep 20, 2022
17790052 METHODS AND COMPOSITIONS FOR BINDING IMMUNOGLOBULIN PROTEIN TARGETING LEVIN, JOEL D 1633 §103 Non-Final OA 42d overdue Pending Jun 29, 2022
17828627 METHOD FOR IMPROVING DIGESTIVE HEALTH MELLER, MICHAEL V 1655 Other Final Rejection 67d overdue Pending May 31, 2022
17827584 COMPOSITIONS AND METHODS FOR TREATING NERVOUS SYSTEM INJURIES BRADLEY, CHRISTINA 1654 Other Final Rejection 103d overdue Pending May 27, 2022
17773775 METABOLIC REPROGRAMMING OF IMMUNE CELLS TO ENHANCE THE EFFICACY OF PROPHYLACTIC AND THERAPEUTIC VACCINES RICCI, CRAIG D 1611 §103 Non-Final OA 97d overdue Pending May 02, 2022
17312855 Models and Methods Useful for the Treatment of Serrated Colorectal Cancer HOLTZMAN, KATHERINE ANN 1646 §103 Non-Final OA 46d overdue Pending Jun 10, 2021

Managing Sanford Burnham Prebys Medical Discovery Institute's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month